l carnitine tmao koeth 2013 nature medicine Revisiting the Role of in Heart Disease Through the Lens of the Gut Microbiota γ–Butyrobetaine is a pro-atherogenic intermediate
Butyrobetaine is a pro atherogenic intermediate in gut microbial metabolism of L carnitine to TMAO PMC Characterization of TMAO productivity from carnitine challenge facilitates personalized nutrition and microbiome signatures discovery Microbiome Springer Nature Link Gut microbiota metabolism of l carnitine and cardiovascular risk Atherosclerosis Frontiers The gut microbial metabolite trimethylamine N oxide and cardiovascular diseases
Pay in 4 interest-free payments of $6.02 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



